Chan, Andrew Hao-Kuang

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016


Léon Betancourt, Alejandro; Schwarzwald, Anina; Millonig, Alban; Oberholzer, Michael; Sabater, Lidia; Hammer, Helly; Kamber, Nicole; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke; Friedli, Christoph (2023). Anti-Kelch-like protein 11 (KLHL11) antibody associated encephalitis -Two case reports and review of the literature. (In Press). European journal of neurology Wiley 10.1111/ene.15758

Single, Michael; Bruhin, Lena C; Schütz, Narayan; Naef, Aileen C; Hegi, Heinz; Reuse, Pascal; Schindler, Kaspar A; Krack, Paul; Wiest, Roland; Chan, Andrew; Nef, Tobias; Gerber, Stephan M (2023). Development of an Open-source and Lightweight Sensor Recording Software System for Conducting Biomedical Research: Technical Report. JMIR formative research, 7(e43092), e43092. JMIR Publications 10.2196/43092

Rebsamen, Michael; McKinley, Richard; Radojewski, Piotr; Pistor, Maximilian; Friedli, Christoph; Hoepner, Robert; Salmen, Anke; Chan, Andrew; Reyes, Mauricio; Wagner, Franca; Wiest, Roland; Rummel, Christian (2023). Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis. Human brain mapping, 44(3), pp. 970-979. Wiley-Blackwell 10.1002/hbm.26117

Rebsamen, Michael; Friedli, Christoph; Radojewski, Piotr; Diem, Lara; Chan, Andrew; Wiest, Roland; Salmen, Anke; Rummel, Christian; Hoepner, Robert (2023). Multiple sclerosis as a model to investigate SARS‐CoV ‐2 effect on brain atrophy. CNS neuroscience & therapeutics, 29(2), pp. 538-543. Wiley 10.1111/cns.14050

Tanasescu, Radu; Chan, Andrew (2023). To predict or not to predict: multiple sclerosis and B cell subset-specific genetic risk scores. European journal of neurology, 30(2), pp. 299-300. Wiley 10.1111/ene.15609

Todea, Alexandra Ramona; Melie-Garcia, Lester; Barakovic, Muhamed; Cagol, Alessandro; Rahmanzadeh, Reza; Galbusera, Riccardo; Lu, Po-Jui; Weigel, Matthias; Ruberte, Esther; Radue, Ernst-Wilhelm; Schaedelin, Sabine; Benkert, Pascal; Oezguer, Yaldizli; Sinnecker, Tim; Müller, Stefanie; Achtnichts, Lutz; Vehoff, Jochen; Disanto, Giulio; Findling, Oliver; Chan, Andrew; ... (2023). A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. (In Press). Journal of magnetic resonance imaging Wiley Interscience 10.1002/jmri.28618

Sanak, Lisa; Kamm, Christian P; Chan, Andrew; Stanikić, Mina; Manjaly, Zina M; Zecca, Chiara; Calabrese, Pasquale; von Wyl, Viktor (2023). Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry. Multiple Sclerosis and Related Disorders, 69, p. 104438. Elsevier 10.1016/j.msard.2022.104438

Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2023). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis journal, 29(1), pp. 63-73. Sage 10.1177/13524585221122210

Aybek, Selma; Chan, Andrew (2023). The borderland of Multiple sclerosis and Functional Neurological Disorder: a call for clinical research and vigilance. European journal of neurology, 30(1), pp. 3-8. Wiley 10.1111/ene.15568

Wiendl, Heinz; Schmierer, Klaus; Hodgkinson, Suzanne; Derfuss, Tobias; Chan, Andrew; Sellebjerg, Finn; Achiron, Anat; Montalban, Xavier; Prat, Alexandre; De Stefano, Nicola; Barkhof, Frederik; Leocani, Letizia; Vermersch, Patrick; Chudecka, Anita; Mwape, Claire; Holmberg, Kristina H; Boschert, Ursula; Roy, Sanjeev (2023). Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy. Neurology: Neuroimmunology and Neuroinflammation, 10(1) Wolters Kluwer Health 10.1212/NXI.0000000000200048

Friedli, Christoph; Salmen, Anke; Hoepner, Robert; Achtnichts, Lutz; Bigi, Sandra; Derfuss, Tobias; Gobbi, Claudio; Kamber, Nicole; Kamm, Christian P; Kuhle, Jens; Lalive, Patrice; Müller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Zecca, Chiara; Chan, Andrew (2023). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and translational neuroscience, 7(1), p. 2. MDPI 10.3390/ctn7010002


Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938

Diem, L; Evangelopoulos, M E; Karathanassis, D; Natsis, V; Kamber, N; Hammer, H; Friedli, C; Chan, A; Helbling, A; Penner, I K; Salmen, A; Walther, S; Stegmayer, K; Hoepner, R (2022). Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? Multiple Sclerosis and Related Disorders, 68, p. 104148. Elsevier 10.1016/j.msard.2022.104148

Chiavi, Deborah; Haag, Christina; Chan, Andrew; Kamm, Christian Philipp; Sieber, Chloé; Stanikić, Mina; Rodgers, Stephanie; Pot, Caroline; Kesselring, Jürg; Salmen, Anke; Rapold, Irene; Calabrese, Pasquale; Manjaly, Zina-Mary; Gobbi, Claudio; Zecca, Chiara; Walther, Sebastian; Stegmayer, Katharina; Hoepner, Robert; Puhan, Milo and von Wyl, Viktor (2022). Studying Real-World Experiences of Persons with Multiple Sclerosis during the first Covid-19 Lockdown: An Application of Natural Language Processing. JMIR medical informatics, 10(11), e37945. JMIR Publications 10.2196/37945

Stanikić, Mina; Salmen, Anke; Chan, Andrew; Kuhle, Jens; Kaufmann, Marco; Ammann, Sabin; Schafroth, Sandra; Rodgers, Stephanie; Haag, Christina; Pot, Caroline; Kamm, Christian P; Zecca, Chiara; Gobbi, Claudio; Calabrese, Pasquale; Manjaly, Zina-Mary; von Wyl, Viktor (2022). Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry. Multiple Sclerosis and Related Disorders, 67, p. 104084. Elsevier 10.1016/j.msard.2022.104084

Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A (2022). Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Multiple Sclerosis and Related Disorders, 65, p. 104015. Elsevier 10.1016/j.msard.2022.104015

Cagol, Alessandro; Schaedelin, Sabine; Barakovic, Muhamed; Benkert, Pascal; Todea, Ramona-Alexandra; Rahmanzadeh, Reza; Galbusera, Riccardo; Lu, Po-Jui; Weigel, Matthias; Melie-Garcia, Lester; Ruberte, Esther; Siebenborn, Nina; Battaglini, Marco; Radue, Ernst-Wilhelm; Yaldizli, Özgür; Oechtering, Johanna; Sinnecker, Tim; Lorscheider, Johannes; Fischer-Barnicol, Bettina; Müller, Stefanie; ... (2022). Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA neurology, 79(7), pp. 682-692. American Medical Association 10.1001/jamaneurol.2022.1025

de Stefano, Nicola; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Wiendl, Heinz; Keller, Birgit; Roy, Sanjeev (2022). Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS. Neurology: neuroimmunology & neuroinflammation, 9(4), e1187. Wolters Kluwer Health 10.1212/NXI.0000000000001187

Guse, Kirsten; Hagemann, Nina; Thiele, Lisa; Remlinger, Jana; Salmen, Anke; Hoepner, Robert; Keller, Irene; Meyer, Patricia; Grandgirard, Denis; Leib, Stephen; Vassella, Erik; Locatelli, Giuseppe; Hermann, Dirk M; Chan, Andrew Hao-Kuang (2022). CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells. Neurology: neuroimmunology & neuroinflammation, 9(4) Wolters Kluwer Health 10.1212/NXI.0000000000001168

Chan, Andrew; Silván, Carlos Vila (2022). Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap. Neurodegenerative disease management, 12(3), pp. 141-154. Future Medicine 10.2217/nmt-2022-0002

Hoepner, Robert; Kamm, Christian; Friedli, Christoph; Salmen, Anke; Chan, Andrew (2022). Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? CNS neuroscience & therapeutics, 28(6), pp. 971-973. Wiley 10.1111/cns.13841

Engelhardt, Britta; Comabella, Manuel; Chan, Andrew (2022). Multiple Sclerosis: Immunopathological heterogeneity and its implications. European journal of immunology, 52(6), pp. 869-881. Wiley-VCH 10.1002/eji.202149757

Hammer, Helly; Kamber, Nicole; Friedli, Christoph; Hoepner, Robert; Diem, Lara; Chan, Andrew; Salmen, Anke (2022). [Primary CNS Vasculitis - An Overview]. Therapeutische Umschau. Revue therapeutique, 79(5), pp. 247-253. Huber 10.1024/0040-5930/a001358

Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L; Salmen, Anke; Hoepner, Robert (2022). Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease, 14, p. 11795735221102727. Sage 10.1177/11795735221102727

Coles, Alasdair J; Jones, Joanne L; Vermersch, Patrick; Traboulsee, Anthony; Bass, Ann D; Boster, Aaron; Chan, Andrew; Comi, Giancarlo; Fernández, Óscar; Giovannoni, Gavin; Kubala Havrdova, Eva; LaGanke, Christopher; Montalban, Xavier; Oreja-Guevara, Celia; Piehl, Fredrik; Wiendl, Heinz; Ziemssen, Tjalf (2022). Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. Multiple sclerosis journal, 28(5), pp. 842-846. Sage 10.1177/13524585211061335

Sidler, Daniel; Born, Alexander; Schietzel, Simeon; Horn, Michael P; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Jafari, S Morteza Seyed; Radonjic-Hoesli, Susanne; Chan, Andrew; Hoepner, Robert; Bacher, Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Suter-Riniker, Franziska; Staehelin, Cornelia; ... (2022). Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy. RMD open, 8(1) BMJ Publishing Group 10.1136/rmdopen-2021-002166

Remlinger, Jana; Madarasz, Adrian; Guse, Kirsten; Hoepner, Robert; Bagnoud, Maud; Meli, Ivo; Feil, Moritz; Abegg, Mathias; Linington, Christopher; Shock, Anthony; Boroojerdi, Babak; Kiessling, Peter; Smith, Bryan; Enzmann, Volker; Chan, Andrew; Salmen, Anke (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis. Neurology: neuroimmunology & neuroinflammation, 9(2) Wolters Kluwer Health 10.1212/NXI.0000000000001134

Hammer, H; Salmen, A; Kamber, N; Friedli, Chr; Diem, L; Hoepner, R; Chan, A (January 2022). Primäre ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift, 2022(1), pp. 46-54.

Hammer, Helly; Hoepner, Robert; Friedli, Christoph; Leib, Stephen L; Suter-Riniker, Franziska; Diem, Lara; Kamber, Nicole; Chan, Andrew; Salmen, Anke; Kamm, Christian P (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), p. 922. MDPI 10.3390/vaccines10060922

Kamm, Christian P; Manjakunnel, Praveen; Lehnick, Dirk; Welter, Martin; Chan, Andrew; Kamber, Nicole; Vanbellingen, Tim (2022). From Diagnosis to Satisfaction in Multiple Sclerosis: A Swiss Patient Survey Highlighting the Importance of the First Diagnostic Consultation. Clinical and translational neuroscience, 6(1), p. 4. MDPI 10.3390/ctn6010004

Pistor, Maximilian; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2022). COVID-19 in a Neuroimmunological Outpatient Cohort: The Bernese Experience. Clinical and translational neuroscience, 6(1), p. 6. MDPI 10.3390/ctn6010006

Pugliatti, Maura; Hartung, Hans-Peter; Oreja-Guevara, Celia; Pozzilli, Carlo; Airas, Laura; Alkhawajah, Mona; Grigoriadis, Nikolaos; Magyari, Melinda; Van Wijmeersch, Bart; Zakaria, Magd; Linker, Ralf; Chan, Andrew; Vermersch, Patrick; Berger, Thomas (2022). Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in. Frontiers in immunology, 13, p. 1045101. Frontiers Research Foundation 10.3389/fimmu.2022.1045101

Pistor, Maximilian; Hoepner, Robert; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke (2022). Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System. Therapeutic advances in neurological disorders, 15(17562864221129383), p. 17562864221129383. Sage 10.1177/17562864221129383


Hunter, Samuel F; Aburashed, Rany A; Alroughani, Raed; Chan, Andrew; Dive, Dominique; Eichau, Sara; Kantor, Daniel; Kim, Ho Jin; Lycke, Jan; Macdonell, Richard A L; Pozzilli, Carlo; Scott, Thomas; Sharrack, Basil; Wiendl, Heinz; Chung, Luke; Daizadeh, Nadia; Baker, Darren P; Vermersch, Patrick (2021). Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies. Neurology and therapy, 10(2), pp. 803-818. Springer 10.1007/s40120-021-00262-3

Pistor, Maximilian; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Annals of the rheumatic diseases, 80(12), pp. 1633-1635. BMJ Publishing Group 10.1136/annrheumdis-2021-220679

Moor, Matthias B.; Suter-Riniker, Franziska; Horn, Michael P.; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M.; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Radonjic-Hoesli, Susanne; Seyed Jafari, S. Morteza; Chan, Andrew; Hoepner, Robert; Bacher, Vera Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Hirzel, Cédric; Maurer, Britta and Sidler, Daniel (2021). Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. The Lancet. Rheumatology, 3(11), e789-e797. Elsevier 10.1016/S2665-9913(21)00251-4

Leys, Didier; Edwards, Mark; Vonck, Kristl; Taba, Pille; Moro, Elena; Chan, Andrew; Sommer, Claudia (2021). SARS-CoV-2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series. European journal of neurology, 28(10), p. 3223. Wiley 10.1111/ene.14905

Hofer, Seline; Bauder, Florian; Capone Mori, Andrea; Chan, Andrew; Dill, Patricia; Garcia-Tarodo, Stéphanie; Goeggel Simonetti, Barbara; Hackenberg, Annette; Kalser, Judith; Maier, Oliver; Schmid, Regula; Strozzi, Susi; Bigi, Sandra (2021). Management of Acute Demyelinating Attacks in the Pediatric Population: A Swiss Consensus Statement. Clinical and translational neuroscience, 5(2), p. 17. MDPI 10.3390/ctn5020017

Oechtering, Johanna; Schaedelin, Sabine; Benkert, Pascal; Müller, Stefanie; Achtnichts, Lutz; Vehoff, Jochen; Disanto, Giulio; Findling, Oliver; Fischer-Barnicol, Bettina; Orleth, Annette; Chan, Andrew; Pot, Caroline; Barakovic, Muhamed; Rahmanzadeh, Reza; Galbusera, Riccardo; Heijnen, Ingmar; Lalive, Patrice H; Wuerfel, Jens; Subramaniam, Suvitha; Aeschbacher, Stefanie; ... (2021). Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Annals of neurology, 90(3), pp. 477-489. Wiley-Blackwell 10.1002/ana.26137

Briner, Myriam; Oberholzer, Michael; Wagner, Franca; Chan, Andrew (2021). Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system. BMJ case reports, 14(8) BMJ Publishing Group 10.1136/bcr-2020-235511

Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Stangel, Martin; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew Hao-Kuang; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; ... (2021). [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt, 92(8), pp. 773-801. Springer 10.1007/s00115-021-01157-2

Diem, Lara; Chan, Andrew (2021). Persisting lymphopenia and dimethyl fumarate: A clinical commentary. Multiple sclerosis journal, 27(8), pp. 1309-1310. Sage 10.1177/1352458521996698

Rodgers, Stephanie; Manjaly, Zina-Mary; Calabrese, Pasquale; Steinemann, Nina; Kaufmann, Marco; Salmen, Anke; Chan, Andrew; Kesselring, Jürg; Kamm, Christian P.; Kuhle, Jens; Zecca, Chiara; Gobbi, Claudio; von Wyl, Viktor; Ajdacic-Gross, Vladeta (2021). The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis. Brain Sciences, 11(6) MDPI 10.3390/brainsci11060751

Rodgers, Stephanie; Calabrese, Pasquale; Ajdacic-Gross, Vladeta; Steinemann, Nina; Kaufmann, Marco; Salmen, Anke; Manjaly, Zina-Mary; Kesselring, Jürg; Kamm, Christian P; Kuhle, Jens; Chan, Andrew; Gobbi, Claudio; Zecca, Chiara; Müller, Stefanie; von Wyl, Viktor (2021). Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population? Journal of psychosomatic research, 144, p. 110402. Elsevier 10.1016/j.jpsychores.2021.110402

Diem, Lara; Friedli, Christoph; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge. Neurology: Neuroimmunology and Neuroinflammation, 8(3) Wolters Kluwer Health 10.1212/NXI.0000000000000991

Diem, L.; Hoepner, R.; Bagnoud, M.; Salmen, A.; Chan, A.; Friedli, C. (2021). Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature. Journal of neuroimmunology, 353, p. 577505. Elsevier 10.1016/j.jneuroim.2021.577505

Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2021). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics, 27(4), pp. 426-438. Wiley 10.1111/cns.13461

Kinner, M; Prehn, C; Schneider, R; Schroeder, C; Kolb, E; Gold, R; Hoepner, R; Chan, A (2021). Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy. European journal of neurology, 28(3), pp. 921-927. Wiley 10.1111/ene.14604

Wipke, Brian T; Hoepner, Robert; Strassburger-Krogias, Katrin; Thomas, Ankur M; Gianni, Davide; Szak, Suzanne; Brennan, Melanie S; Pistor, Maximilian; Gold, Ralf; Chan, Andrew; Scannevin, Robert H (2021). Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology: Neuroimmunology and Neuroinflammation, 8(2) Wolters Kluwer Health 10.1212/NXI.0000000000000950

Torkildsen, Øivind; Linker, Ralf A; Sesmero, Jose Mm; Fantaccini, Simone; Sanchez-de, la Rosa Rainel; Seze, Jerome de; Duddy, Martin; Chan, Andrew (2021). Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders. Neurodegenerative disease management, 11(1), pp. 9-19. Future Medicine 10.2217/nmt-2020-0054

Fortunato, Remo; van der Maas, Nico Arie; Biland-Thommen, Ursula; Kaufmann, Marco; Sieber, Chloé; Kamm, Christian P.; Zecca, Chiara; Gobbi, Claudio; Chan, Andrew; Calabrese, Pasquale; Kesselring, Jürg; von Wyl, Viktor (2021). Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis. Multiple Sclerosis and Related Disorders, 48(102710), p. 102710. Elsevier 10.1016/j.msard.2020.102710

McKinley, Richard; Wepfer, Rik; Aschwanden, Fabian; Grunder, Lorenz; Muri, Raphaela; Rummel, Christian; Verma, Rajeev; Weisstanner, Christian; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wagner, Franca; Wiest, Roland (2021). Simultaneous lesion and brain segmentation in multiple sclerosis using deep neural networks. Scientific reports, 11(1), p. 1087. Springer Nature 10.1038/s41598-020-79925-4

Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders, 14, p. 17562864211016641. Sage 10.1177/17562864211016641

Kallmann, Boris A; Ries, Stefan; Kullmann, Jennifer S; Quint, Laura M; Engelmann, Ulrich; Chan, Andrew (2021). Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Therapeutic advances in neurological disorders, 14, p. 17562864211005588. Sage 10.1177/17562864211005588

Gili-Kovács, Judit; Hoepner, Robert; Salmen, Anke; Bagnoud, Maud; Gold, Ralf; Chan, Andrew; Briner, Myriam (2021). An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic advances in neurological disorders, 14, p. 17562864211020074. Sage 10.1177/17562864211020074

Chaloulos-Iakovidis, Panagiotis; Wagner, Franca; Weber, Lea; Diem, Lara; Chan, Andrew; Salmen, Anke; Friedli, Christoph; Hoepner, Robert (2021). Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Therapeutic advances in neurological disorders, 14, p. 17562864211030664. Sage 10.1177/17562864211030664

Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; ... (2021). Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders, 14, p. 17562864211039648. Sage 10.1177/17562864211039648


Graber, Michael; Chan, Andrew (2020). Multiple Sklerose und Schwangerschaft. Psychiatrie + Neurologie, 2020(5), pp. 4-9. Rosenfluh

Bagnoud, Maud; Briner, Myriam; Remlinger, Jana; Meli, Ivo; Schuetz, Sara; Pistor, Maximilian; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2020). c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells, 9(10) MDPI 10.3390/cells9102154

Barin, Laura; Kamm, Christian P.; Salmen, Anke; Dressel, Holger; Calabrese, Pasquale; Pot, Caroline; Schippling, Sven; Gobbi, Claudio; Müller, Stefanie; Chan, Andrew; Rodgers, Stephanie; Kaufmann, Marco; Ajdacic-Gross, Vladeta; Steinemann, Nina; Kesselring, Jürg; Puhan, Milo A; von Wyl, Viktor (2020). How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis. Multiple sclerosis journal, 26(4), pp. 489-500. Sage 10.1177/1352458518823955

Diem, Lara; Daponte, Ariadne; Findling, Oliver; Miclea, Andrei; Briner, Myriam; Salmen, Anke; Gold, Ralf; Kilidireas, Constantinos; Chan, Andrew; Evangelopoulos, Maria Elftheria; Hoepner, Robert (2020). Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study. Neurology: Neuroimmunology and Neuroinflammation, 7(2) Wolters Kluwer Health 10.1212/NXI.0000000000000660

Gómez-Fernández, Paloma; Lopez de Lapuente Portilla, Aitzkoa; Astobiza, Ianire; Mena, Jorge; Urtasun, Andoni; Altmann, Vivian; Matesanz, Fuencisla; Otaegui, David; Urcelay, Elena; Antigüedad, Alfredo; Malhotra, Sunny; Montalban, Xavier; Castillo-Triviño, Tamara; Espino-Paisán, Laura; Aktas, Orhan; Buttmann, Mathias; Chan, Andrew; Fontaine, Bertrand; Gourraud, Pierre-Antoine; Hecker, Michael; ... (2020). The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis. Cells, 9(1) MDPI 10.3390/cells9010175

Thiele née Schrewe, Lisa; Guse, Kirsten; Tietz, Silvia; Remlinger, Jana; Demir, Seray; Pedreiturria, Xiomara; Hoepner, Robert; Salmen, Anke; Pistor, Maximilian; Turner, Timothy; Engelhardt, Britta; Hermann, Dirk M; Lühder, Fred; Wiese, Stefan; Chan, Andrew (2020). Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. Journal of neuroinflammation, 17(1), p. 9. BioMed Central 10.1186/s12974-019-1677-z

Chan, Andrew; Rose, John; Alvarez, Enrique; Bar-Or, Amit; Butzkueven, Helmut; Fox, Robert J.; Gold, Ralf; Gudesblatt, Mark; Haartsen, Jodi; Spelman, Tim; Wright, Katy; Ferraro, Diana; Sola, Patrizia; Hodgkinson, Suzanne; Kalincik, Tomas; Lechner-Scott, Jeannette; McGuigan, Christopher; Spach, Karen; Chongshu, Chen; Fam, Sami; ... (2020). Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurology: Clinincal Practice, 10(6), pp. 510-519. American Academy of Neurology 10.1212/CPJ.0000000000000800

Miclea, Andrei; Bagnoud, Maud; Chan, Andrew; Hoepner, Robert (2020). A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Frontiers in immunology, 11(781), p. 781. Frontiers Research Foundation 10.3389/fimmu.2020.00781

Diem, Lara; Bürge, Maxine; Leichtle, Alexander; Hakim, Arsany; Chan, Andrew; Salmen, Anke; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2020). Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study. Therapeutic advances in neurological disorders, 13, p. 175628642097590. Sage 10.1177/1756286420975909

McKinley, Richard; Wepfer, Rik; Grunder, Lorenz; Aschwanden, Fabian; Fischer, Tim; Friedli, Christoph; Muri, Raphaela; Rummel, Christian; Verma, Rajeev Kumar; Weisstanner, Christian; Wiestler, Benedikt; Berger, Christoph; Eichinger, Paul; Muehlau, Mark; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wiest, Roland; Wagner, Franca (2020). Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence. NeuroImage: Clinical, 25, p. 102104. Elsevier 10.1016/j.nicl.2019.102104

McKinley, Richard; Wepfer, Rik; Aschwanden, Fabian; Grunder, Lorenz; Muri, Raphaela; Rummel, Christian; Verma, Rajeev; Weisstanner, Christian; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wagner, Franca; Wiest, Roland (2020). Robustness of Simultaneous Lesion and Neuroanatomy Segmentation in Multiple Sclerosis Using Deep Neural Networks (In Press). SSRN Electronic Journal Elsevier 10.2139/ssrn.3529469


Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8

Min, Jinny; Cohan, Stanley; Alvarez, Enrique; Sloane, Jacob; Phillips, J Theodore; van der Walt, Anneke; Koulinska, Irene; Fang, Fang; Miller, Catherine; Chan, Andrew (2019). Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes. Neurology and therapy, 8(1), pp. 109-119. Springer 10.1007/s40120-019-0127-2

Ambrosius, Björn; Gold, Ralf; Chan, Andrew; Faissner, Simon (2019). Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy. Neurology: Neuroimmunology and Neuroinflammation, 6(3), e551. Wolters Kluwer Health 10.1212/NXI.0000000000000551

Miclea, A.; Salmen, Anke; Zoehner, G.; Diem, Lara; Kamm, Christian P.; Chaloulos-Iakovidis, Panagiotis; Miclea, M.; Briner, Myriam Sandra; Kilidireas, K.; Stefanis, L.; Chan, Andrew; Evangelopoulos, Maria Eleptheria; Hoepner, Robert (2019). Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. CNS neuroscience & therapeutics, 25(4), pp. 527-531. Blackwell Publishing 10.1111/cns.13083

Barin, L.; Kaufmann, M.; Salmen, Anke; Kamm, Christian P.; Gobbi, C.; Kuhle, J.; Pot, C.; Chan, Andrew; Czaplinski, A.; Ajdacic-Gross, V.; Rodgers, S.; Kesselring, J.; Puhan, M. A.; von Wyl, V. (2019). Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study. Multiple Sclerosis and Related Disorders, 28, pp. 17-25. Elsevier 10.1016/j.msard.2018.11.033

Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450

Manrique-Castano, Daniel; Sardari, Maryam; Silva de Carvalho, Tayana; Doeppner, Thorsten R; Popa-Wagner, Aurel; Kleinschnitz, Christoph; Chan, Andrew; Hermann, Dirk M (2019). Deactivation of ATP-Binding Cassette Transporters ABCB1 and ABCC1 Does Not Influence Post-ischemic Neurological Deficits, Secondary Neurodegeneration and Neurogenesis, but Induces Subtle Microglial Morphological Changes. Frontiers in cellular neuroscience, 13(412), p. 412. Frontiers Research Foundation 10.3389/fncel.2019.00412

Kluser, Stephanie; Chan, Andrew; Meier, Niklaus (2019). When “unclear headache” has an obvious reason—Applying ID-Migraine™ to referral letters. Cephalalgia reports, 2, p. 251581631986620. Sage 10.1177/2515816319866207

Achtnichts, Lutz; Chan, Andrew; Czaplinski, Adam; Derfuss, Tobias; Du Pasquier, Renaud; Findling, Oliver; Gobbi, Claudio; Hoepner, Robert; Kamber, Nicole; Kamm, Christian P.; Kuhle, Jens; Lalive, Patrice; Lutterotti, Andreas; Martin, Roland; Mller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Salmen, Anke; Schippling, Sven and Zecca, Chiara (2019). Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz. Swiss Medical Forum, 19(41-42), pp. 676-685. EMH Swiss Medical Publishers 10.4414/smf.2019.08356

Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340

Skorupka, Nic; Miclea, Andrei; Jalowiec, Katarzyna Aleksandra; Bocksrucker, Christoph; Kamber, Nicole; Chan, Andrew; Mansouri Taleghani, Behrouz; Hoepner, Robert; Salmen, Anke (2019). Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfusion medicine and hemotherapy, 46(6), pp. 417-422. Karger 10.1159/000504027

Kallmann, Boris A; Tiel-Wilck, Klaus; Kullmann, Jennifer S; Engelmann, Ulrich; Chan, Andrew (2019). Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study. Therapeutic advances in neurological disorders, 12, p. 1756286419835077. Sage 10.1177/1756286419835077

Kamber, Nicole; Chan, Andrew (2019). Multiple Sklerose. Länder-spezifische Aspekte der Indikation und Sicherheit aktueller Therapien. Info Neurologie & Psychiatrie, 17(20) Prime Public Media AG

Linker, Ralf A.; Chan, Andrew Hao-Kuang (2019). Navigating choice in multiple sclerosis management. Neurological research and practice, 1(1), pp. 1-8. BioMed Central 10.1186/s42466-019-0005-5

Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073

Classen, G.; Classen, C.; Bernasconi, Corrado Angelo; Brandt, C.; Gold, R.; Chan, Andrew; Hoepner, Robert (2019). Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Journal of neurovirology, 25(1), pp. 133-136. Springer 10.1007/s13365-018-0689-2

Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652

Maeder, Cecilia; Friedli, Christoph; Kuchen, Stefan; Wiest, Roland; Hewer, Ekkehard; Rovó, Alicia; Chan, Andrew (2019). Langerhans cell histiocytosis with initial central nervous system presentation as a mimic of neurosarcoidosis. Clinical and translational neuroscience, 3(2), 2514183X1987506. Sage Publications 10.1177/2514183x19875064

McKinley, Richard; Grunder, Lorenz; Wepfer, Rik; Aschwanden, Fabian; Fischer, Tim; Friedli, Christoph; Muri, Raphaela; Rummel, Christian; Verma, Rajeev; Weisstanner, Christian; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wiest, Roland; Wagner, Franca (2019). Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence (arXiv). Cornell University


Kaufmann, M.; Kuhle, J.; Puhan, M. A.; Kamm, Christian Philipp; Chan, Andrew; Salmen, Anke; Kesselring, J.; Calabrese, P.; Gobbi, C.; Pot, C.; Steinemann, N.; Rodgers, S.; von Wyl, V. (2018). Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland. Multiple sclerosis journal - experimental, translational and clinical, 4(4), p. 2055217318814562. Sage Publications 10.1177/2055217318814562

Evangelopoulos, Maria Eleftheria; Miclea, Andrei; Schrewe, Lisa; Briner, Myriam; Salmen, Anke; Engelhardt, Britta; Huwiler, Andrea; Chan, Andrew; Hoepner, Robert (2018). Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod. CNS neuroscience & therapeutics, 24(10), pp. 984-986. Wiley 10.1111/cns.12992

Bern University (2018). mTOR Inhibitor-Corticoid Combination Therapy For Multiple Sclerosis (WO 2018/153984 A1)

Pistor, Maximilian; Schrewe, Lisa; Haupeltshofer, Steffen; Miclea, Andrei; Faissner, Simon; Chan, Andrew; Hoepner, Robert (2018). 1,25-OH vitamin D and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL). Leukemia research reports, 9, pp. 38-41. Elsevier 10.1016/j.lrr.2018.01.003

Barin, Laura; Salmen, Anke; Disanto, Giulio; Babačić, Haris; Calabrese, Pasquale; Chan, Andrew; Kamm, Christian P.; Kesselring, Jürg; Kuhle, Jens; Gobbi, Claudio; Pot, Caroline; Puhan, Milo A.; von Wyl, Viktor (2018). The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Multiple Sclerosis and Related Disorders, 25, pp. 112-121. Elsevier 10.1016/j.msard.2018.07.013

Kelemen, Peter; Alaoui, Jamila; Sieron, Dominik; Chan, Andrew; Kamm, Christian P.; Heldner, Mirjam R.; Gralla, Jan; Wiest, Roland; Verma, Rajeev K. (2018). T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White Matter. Scientific Reports, 8(1), p. 16844. Nature Publishing Group 10.1038/s41598-018-35186-w

Chan, Andrew; Kamber, Nicole; Hoepner, Robert; Salmen, Anke (2018). Fortschritte in der Therapie der Multiplen Sklerose. Therapeutische Umschau, 75(7), pp. 405-409. Huber 10.1024/0040-5930/a001016

Wagner, Franca; Grunder, Lorenz Nicolas; Hakim, Arsany; Kamber, Nicole; Horn, Michael; Müllner, Julia Nicole Maria; Hoepner, Robert; Wiest, Roland; Metz, Imke; Chan, Andrew; Salmen, Anke (2018). Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in neurology, 9(782), p. 782. Frontiers Media S.A. 10.3389/fneur.2018.00782

Rummel, Christian; Aschwanden, Fabian; McKinley, Richard; Wagner, Franca; Salmen, Anke; Chan, Andrew; Wiest, Roland (2018). A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease. Frontiers in neurology, 8, p. 727. Frontiers Media S.A. 10.3389/fneur.2017.00727


Chan, Andrew (2017). Clinical commentary on 'Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis', by Foley et al. Multiple sclerosis journal, 23(10), pp. 1427-1429. Sage 10.1177/1352458517712868

Miclea, Andrei; Miclea, Marius; Pistor, Maximilian; Hoepner, Andreas; Chan, Andrew; Hoepner, Robert (2017). Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity. Brain and Behavior, 7(8), e00761. Wiley 10.1002/brb3.761

Chan, Andrew; Cutter, Gary; Fox, Robert J; Xiao, James; Lewin, James B; Edwards, Michael R (2017). Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison. Journal of comparative effectiveness research, 6(4), pp. 313-323. Future Medicine 10.2217/cer-2016-0085

Ambrosius, Björn; Faissner, Simon; Guse, Kirsten; von Lehe, Marec; Grunwald, Thomas; Gold, Ralf; Grewe, Bastian; Chan, Andrew (2017). Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. Journal of neuroinflammation, 14(1), p. 51. BioMed Central 10.1186/s12974-017-0829-2

Salmen, Anke; Chan, Andrew (2017). NMO-Spektrum-Erkrankungen (NMOSE). In: Berlit, P (ed.) Klinische Neurologie. Springer Reference Medizin (pp. 1-15). Berlin; Heidelberg: Springer 10.1007/978-3-662-44768-0_161-1


Kinner, Markus; Hoepner, Robert; Klotz, Peter; Prehn, Christian; Faissner, Simon; Salmen, Anke; Linker, Ralf A; Gold, Ralf; Chan, Andrew (2016). Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis. CNS neuroscience & therapeutics, 22(12), pp. 1019-1022. Wiley 10.1111/cns.12652

Fox, Robert J; Chan, Andrew; Zhang, Annie; Xiao, James; Levison, Dane; Lewin, James B; Edwards, Michael R; Marantz, Jing L (2016). Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis. Current medical research and opinion, 33(2), pp. 1-23. Informa Healthcare 10.1080/03007995.2016.1248380

Faissner, Simon; Lukas, Carsten; Chan, Andrew; Gold, Ralf; Krogias, Christos (2016). "Punched nerve syndrome" as contributing factor for "Saturday night palsy". Journal of the neurological sciences, 368, pp. 173-174. Elsevier 10.1016/j.jns.2016.07.012

Hoepner, Robert; Kolb, Eva M; Dahlhaus, Stefanie; Hellwig, Kerstin; Adams, Ortwin; Kleiter, Ingo; Salmen, Anke; Schneider, Ruth; Lukas, Carsten; Chan, Andrew; Berger, Joseph R; Gold, Ralf (2016). Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple sclerosis journal, 23(6), pp. 830-835. Sage 10.1177/1352458516667241

Faissner, Simon; Nikolayczik, Johanna; Chan, Andrew; Gold, Ralf; Yoon, Min-Suk; Haghikia, Aiden (2016). Immunoadsorption in patients with neuromyelitis optica spectrum disorder. Therapeutic advances in neurological disorders, 9(4), pp. 281-286. Sage 10.1177/1756285616646332

Andlauer, Till F M; Buck, Dorothea; Antony, Gisela; Bayas, Antonios; Bechmann, Lukas; Berthele, Achim; Chan, Andrew; Gasperi, Christiane; Gold, Ralf; Graetz, Christiane; Haas, Jürgen; Hecker, Michael; Infante-Duarte, Carmen; Knop, Matthias; Kümpfel, Tania; Limmroth, Volker; Linker, Ralf A; Loleit, Verena; Luessi, Felix; Meuth, Sven G; ... (2016). Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science Advances, 2(6), e1501678. American Association for the Advancement of Science 10.1126/sciadv.1501678

Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1

Fox, Robert J; Chan, Andrew; Gold, Ralf; Phillips, J Theodore; Selmaj, Krzysztof; Chang, Ih; Novas, Mark; Rana, Jitesh; Marantz, Jing L (2016). Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS: Patient management considerations. Neurology. Clinical practice, 6(3), pp. 220-229. American Academy of Neurology 10.1212/CPJ.0000000000000238

Faissner, Simon; Nikolayczik, Johanna; Chan, Andrew; Hellwig, Kerstin; Gold, Ralf; Yoon, Min-Suk; Haghikia, Aiden (2016). Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses. Journal of neurology, 263(6), pp. 1092-1098. Springer-Medizin-Verlag 10.1007/s00415-016-8105-4

Chan, Andrew; de Seze, Jérôme; Comabella, Manuel (2016). Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis. CNS drugs, 30(1), pp. 41-51. Springer 10.1007/s40263-015-0299-y

Sehr, T; Proschmann, U; Thomas, K; Marggraf, M; Straube, E; Reichmann, H; Chan, Andrew; Ziemssen, T (2016). New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies. Journal of neuroinflammation, 13(1), p. 164. BioMed Central 10.1186/s12974-016-0635-2

Sadovnick, A Dessa; Traboulsee, Anthony L; Bernales, Cecily Q; Ross, Jay P; Forwell, Amanda L; Yee, Irene M; Guillot-Noel, Lena; Fontaine, Bertrand; Cournu-Rebeix, Isabelle; Alcina, Antonio; Fedetz, Maria; Izquierdo, Guillermo; Matesanz, Fuencisla; Hilven, Kelly; Dubois, Bénédicte; Goris, An; Astobiza, Ianire; Alloza, Iraide; Antigüedad, Alfredo; Vandenbroeck, Koen; ... (2016). Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients. G3 Genes Genomes Genetics, 6(7), pp. 2073-2079. Genetics Society of America 10.1534/g3.116.030841

Salmen, Anke; von Ahsen, N.; Trampe, A. K.; Hoepner, R.; Plavina, T.; Subramanyam, M.; Kuesters, G.; Gold, R.; Chan, Andrew (2016). Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy. Multiple sclerosis journal - experimental, translational and clinical, 2, p. 205521731663000. Sage Publications 10.1177/2055217316630008

Disanto, Giulio; Benkert, Pascal; Lorscheider, Johannes; Mueller, Stefanie; Vehoff, Jochen; Zecca, Chiara; Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen; Radue, Ernst-Wilhelm; Sprenger, Till; Stippich, Christoph; Derfuss, Tobias; Louvion, Jean-François; Kamm, Christian Philipp; Mattle, Heinrich; Lotter, Christoph; Du Pasquier, Renaud; Schluep, Myriam; ... (2016). The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PLoS ONE, 11(3), e0152347. Public Library of Science 10.1371/journal.pone.0152347

Provide Feedback